AstraZeneca

Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report
Fierce Pharma
Sun, 01/8/23 - 09:57 pm
Pfizer
Merck
JNJ
Novo Nordisk
AstraZeneca
FDA starts review of Sanofi, AZ antibody for RSV prevention
Pharmaphorum
Thu, 01/5/23 - 10:20 am
RSV
Sanofi
AstraZeneca
FDA
antibodies
nirsevimab
COVID-19 tracker: AstraZeneca workers who were fired for refusing vaccine file lawsuit
Fierce Pharma
Wed, 01/4/23 - 10:06 am
AstraZeneca
vaccines
COVID-19
age discrimination
legal
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
clinical trials
Alzheimer's disease
obesity
Huntington's disease
M&A
AstraZeneca
Daiichi Sankyo
Nimbus Therapeutics
Takeda
Eli Lilly
Sanofi
Regeneron
Moderna Therapeutics
Gilead Sciences
Pfizer
Roivant
Alnylam
uniQure
AstraZeneca, Merck's Lynparza wins EU nod in advanced prostate cancer right after FDA delay
Fierce Pharma
Wed, 12/21/22 - 12:40 pm
AstraZeneca
Merck
Lynparza
Europe
prostate cancer
advanced prostate cancer
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
Motley Fool
Tue, 12/20/22 - 10:44 am
AstraZeneca
asthma
PT027
Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec
Fierce Pharma
Mon, 12/19/22 - 12:29 pm
AstraZeneca
Imfinzi
lung cancer
non-small cell lung cancer
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
AstraZeneca
Daiichi Sankyo
Pfizer
Roche
CSL
uniQure
Novo Nordisk
Eli Lilly
AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort
Fierce Pharma
Fri, 12/16/22 - 11:08 am
AstraZeneca
Symbicort
patents
Viatris
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
AstraZeneca
Alexion
PNH
Ultomiris
Soliris
Roche
Apellis
Novartis
AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer
Fierce Pharma
Thu, 12/15/22 - 11:01 am
AstraZeneca
Merck
Lynparza
FDA
metastatic castration-resistant prostate cancer
ASH: Novartis says rare disease med 'stands on its own,' diving deeper into head-to-head win against AstraZeneca
Fierce Biotech
Tue, 12/13/22 - 10:28 am
ASH 2022
Novartis
iptacopan
AstraZeneca
ASH: Roche records phase 3 rare disease win ahead of Soliris showdown
Fierce Biotech
Mon, 12/12/22 - 10:29 am
ASH 2022
Roche
PNH
crovalimab
AstraZeneca
Soliris
AstraZeneca-Daiichi Sankyo’s therapy shows response in breast cancer trials
Clinical Trials Arena
Mon, 12/12/22 - 10:26 am
AstraZeneca
Daiichi Sankyo
clinical trials
datopotamab deruxtecan
metastatic triple-negative breast cancer
breast cancer
SABCS: AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla
Fierce Pharma
Fri, 12/9/22 - 10:54 am
SABCS
AstraZeneca
Enhertu
breast cancer
Daiichi Sankyo
Roche
Kadcyla
Setting the Stage for ASH 2022
BioSpace
Fri, 12/9/22 - 10:50 am
ASH 2022
AstraZeneca
Janssen
Merck
Vega Therapeutics
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
Fri, 12/9/22 - 10:46 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Gilead Sciences
With Neogene buy and a CAR-T in the clinic, AstraZeneca builds up cell therapy 'library'
Fierce Biotech
Mon, 12/5/22 - 11:04 am
AstraZeneca
Neogene Therapeutics
CAR-T
cell therapy
cell library
AstraZeneca Deepens Cancer Cell Therapy Portfolio with Neogene Buyout
BioSpace
Tue, 11/29/22 - 11:12 am
AstraZeneca
Neogene Therapeutics
M&A
cancer
cell therapy
Lundbeck-partnered preclinical biotech nabs Series A from AstraZeneca
Endpoints
Tue, 11/29/22 - 11:00 am
Rgenta Therapeutics
AstraZeneca
funding
small molecule drugs

Pages